Shree Anand Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 24.00 Cr
as on 21-06-2024
- Paid Up Capital ₹ 14.61 Cr
as on 21-06-2024
- Company Age 18 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 94.32 Cr
as on 21-06-2024
- Satisfied Charges ₹ 36.54 Cr
as on 21-06-2024
- Revenue 374.46%
(FY 2022)
- Profit -10910.29%
(FY 2022)
- Ebitda -414.93%
(FY 2022)
- Net Worth -217.15%
(FY 2022)
- Total Assets -4.02%
(FY 2022)
About Shree Anand Life Sciences
The Corporate was formerly known as Shree Anand Life Sciences Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 24.00 Cr and a paid-up capital of Rs 14.61 Cr.
The company currently has active open charges totaling ₹94.32 Cr. The company has closed loans amounting to ₹36.54 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Shree Anand Life Sciences Limited India is Shivalingappa Karadi as CFO. Satish Gharge, Sanjay Gharge, Gharge Satish, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24232KA2006PLC040855
- Company No.
040855
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
06 Nov 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Belgaum, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Shree Anand Life Sciences?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Satish Gharge | Managing Director | 06-Nov-2006 | Current |
Shivalingappa Karadi | CFO | 01-Apr-2018 | Current |
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sanjay Gharge | Director | 06-Nov-2006 | Current |
Gharge Satish | Director | 06-Nov-2006 | Current |
Aishwarya Gharge | Director | 12-Mar-2018 | Current |
Virendra Pawar | Director | 09-Sep-2015 | Current |
Financial Performance of Shree Anand Life Sciences.
Shree Anand Life Sciences Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 374.46% increase. The company also saw a substantial fall in profitability, with a 10910.29% decrease in profit. The company's net worth observed a substantial decline by a decrease of 217.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Shree Anand Life Sciences?
In 2022, Shree Anand Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 31 Mar 2022 | ₹9.00 Cr | Open |
Hdfc Bank Limited Creation Date: 01 Dec 2021 | ₹3.20 M | Open |
Others Creation Date: 26 Apr 2017 | ₹85.00 Cr | Open |
How Many Employees Work at Shree Anand Life Sciences?
Shree Anand Life Sciences has a workforce of 156 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shree Anand Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Anand Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.